Search
Press Releases
Search Archive:  

 

South Africa Pharmaceutical industry to Grow 22% by 2013

Feb 20, 2010
Share |
 

According to our new research report "South African Healthcare Market Analysis", the pharmaceutical industry in South Africa has been continuously growing despite the concerns of drug inflation. The pharmaceutical industry future remains pleasantly buoyant and it is expected to grow at a CAGR of around 22% during 2010-2013. The optimistic outlook for the industry is based on the fact that private players are making intensive investments.

We have done an extensive research and prudent analysis of the South African pharmaceutical industry in order to understand the factors that will continue to serve as growth driver for the pharma market in South Africa over the forecast period (2010-2013). We have found that several factors such as growing healthcare spending and burden of diseases (HIV/AIDS, TB, Diabetes, etc.) have boosted the usage of high-priced drugs in the country. Moreover, there will be high demand for primary health care level drugs such as generics, antibiotics and OTC drugs in coming years owing to the fact that a number of drugs will lose their patents. The report also gives insight into the role of government to regulate the pharmaceutical companies in South Africa. Besides, several other factors propelling growth in the pharmaceutical industry have been thoroughly evaluated in the report.

Our research indicates that the South African healthcare industry has an immense growth potential and is in the initial stages of development. There is a high demand for hospitals services and healthcare professionals. The country is highly dependent on imported drugs, thereby giving room to private players to set up their own manufacturing bases. It also gives an overview of the factors that may hinder healthcare industry growth in coming years.

"South African Healthcare Market Analysis"" provides a thorough research and rational analysis along with reliable statistics of the South African healthcare industry. It covers major industries, segment-wise break up and information about major emerging segments. The report has thoroughly examined current market trends, industrial developments and competitive landscape to enable clients understand the market structure and its progress in coming years.

For more information visit: http://www.rncos.com/Report/IM248.htm


Related Press Releases:
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
» US Drug Spending – Reaching Soaring Rates
» Global Genetic Testing Market worth US$ 1.5 Billion, to Grow Significantly
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Check out our latest reports on What’s New page.
Not able to find the data you are looking for?
Consider requesting a
Custom Research Proposal.
Home | About Us | Careers | Request a Quote | Discounted Reports | Contact Us | Resources | Add URL | FAQ | Upcoming Reports
Copyright © 2012, RNCOS, 2002-2012
Phone : +91 (120) 4224700/01/02/03 Fax : +91 (120) 4224707